Too Much of a Good Thing is Bad, Especially Drugs

break(great for any design)

Many of us have not reached the the point in our lives where we are trying to reverse the effects of father time and because of this we may not know what much about the company Allergan. Allergan is the company that makes Botox, a prescription drug that is injected into the skin to help alleviate wrinkles. But this is not all they do, Allergan is a  $53 billion pharmaceutical company with an inventory of products ranging from headache to glaucoma medication.

Recently Allergan was in talks to acquire Salix Pharmaceutical Ltds, a company that specializes in a bowel medication, but during the due diligence Allergan spotted something that threw the deal off. This key detail that ended the acquisition of the $9 billion company was inventory. Salix management seemed to have misjudged how much inventory they had and had overstated the amount sold. This meant that Salix has a large amount of inventory on hand, which we know is one of the most expensive asset of a company, that they could not sell to make revenue.  Another problem with this is that these products were finished goods meaning that they were not raw materials or even work in progress products so this prohibited them from re-purposing the drug.

The effects of inventory is profound. The effects of a misjudged inventory estimate is devastating. In this case not only has Salix lost the chance to pay back stakeholders by being bought out by a large corporation such as Allergan, Allergan may have lost it’s chance to protect themselves from a takeover. Allergan is in the midst of being taken over by an even bigger pharmaceutical company, Valient Pharmaceuticals International Inc. The acquisition of Salix was suppose to make them too expensive to be taken over, but because of this inventory mistake they are ripe for the taking.

As shown above inventory is a major factor in a company, whether they want to be bought out or are just running their daily operations. The management of inventory is crucial to a companies daily operations in that the company needs to have enough inventory for the demand but not too much that a company does not seem liquid enough. The company also needs to balance the right amount so that their financial standings are not in question. Not only do managers need to understand how inventory needs to be ordered they need to what type of inventory needs to be ordered.  Balancing inventory is something that will take a lot of experience and knowledge to achieve , hopefully we all reach a point in our careers where we are at this level.

Do you think Allergan should not have put so much weight on the inventory of Salix ?

Are you surprised that Allergan did not go through with the acquisition of Salix if it meant they would not be taken over?

http://online.wsj.com/articles/salix-shares-plunge-as-accounting-revision-showed-weak-drug-sales-1415321484

http://www.reuters.com/article/2014/11/07/us-salixpharmaceuticals-results-idUSKBN0IQ2LN20141107

http://www.bloomberg.com/news/2014-10-02/salix-said-in-talks-to-sell-to-actavis-as-allergan-fades.html

 

One thought on “Too Much of a Good Thing is Bad, Especially Drugs

  1. Interesting post. I think inventory is important as it affects a company’s liquidity. Case and point, the quick ratio, a common measure of liquidity, does not include inventory due to the difficulty of quickly selling it off if the company needs to pay its creditors. Allergan was wise to avoid taking on more inventory from Salix as it would have affected the company’s financial position. Potential investors and lenders may have condemned the company had they done the deal, so Allergan avoided the situation all together.

Leave a Reply

Your email address will not be published. Required fields are marked *